|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2005
vol. 107 abstract:
Original paper
The analysis of I125 brachytherapy complications in cases of uveal melanoma
Arkadiusz Pogrzebielski
1
,
Maria Starzycka
1
,
Bożena Romanowska-Dixon
1
,
Barbara Jakubowska
1
,
Urszula Szpakowicz
1
Klinika Oczna 2005, 107(1-3): 49-53
Online publish date: 2005/03/15
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction
Analysis of type and frequency of complications after brachytherapy I125 between 1–12 months after treatment and during the following controls. Material and methods 147 persons (76 men and 71 women) aged 23–86 years (mean 57 years), were treated in our clinic in 1998–2001. In 43% of the cases the thickness of the tumor was more than 8 mm and in 94% the maximum diameter was bigger than 8.1 mm. The irradiation dose was 80–120 Gy, mean 100 Gy. Results Regression and stabilization of the tumor was achieved in 84,3% of all cases. Complications of different type and intensity associated with brachytherapy I125 were observed in majority of the cases. The complications observed were: radiation retinopathy (52%), radiation maculopathy (33,6%), radiation optic neuropathy (25,3%), vitreous hemorrhage (8,8%), glaucoma (20,5%) and cataract (18,5%). Conclusions 125I brachytherapy yields good results in cases of uveal melanoma, however it’s associated with post radiation complications. keywords:
choroidal melanoma, uveal melanoma, brachytherapy I125, radiation retinopathy, radiation maculopathy, radiation optic neuropathy, consecutive glaucoma and cataract |
|
POLSKI
